SEARCH RESULTS FOR: (*Imitation Ecole Nationale d*)(525 results)

Export results
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Ensemble™ ll - 00643169713901

DELIV SYS ENS1022 ENSEMBLE II US
MEDTRONIC, INC.
ENS1022
In Commercial Distribution

  • 00643169713901 ()

  • Outer Balloon Size 22 mm


  • Pulmonary transcatheter heart valve bioprosthesis

Ensemble™ ll - 00643169713895

DELIV SYS ENS1020 ENSEMBLE II US
MEDTRONIC, INC.
ENS1020
In Commercial Distribution

  • 00643169713895 ()

  • Outer Balloon Size 20 mm


  • Pulmonary transcatheter heart valve bioprosthesis

Ensemble™ ll - 00643169713888

DELIV SYS ENS1018 ENSEMBLE II US
MEDTRONIC, INC.
ENS1018
In Commercial Distribution

  • 00643169713888 ()

  • Outer Balloon Size 18 mm


  • Pulmonary transcatheter heart valve bioprosthesis

Lixelle - 14993478020232

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
Not in Commercial Distribution

  • 24993478020239 ()
  • 14993478020232 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column

Lixelle - 14993478020225

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
Not in Commercial Distribution

  • 24993478020222 ()
  • 14993478020225 ()
  • 04993478010069 ()
N/A

  • Haemoperfusion system absorption column

Lixelle - 14993478020218

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
Not in Commercial Distribution

  • 14993478020218 ()
  • 04993478010052 ()
  • 24993478020215 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010066

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
In Commercial Distribution

  • 04993478010069 ()
  • 14993478010066 ()
  • 24993478010063 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010059

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
In Commercial Distribution

  • 04993478010052 ()
  • 14993478010059 ()
  • 24993478010056 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010042

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
In Commercial Distribution

  • 24993478010049 ()
  • 14993478010042 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column

LVIS - 00810170019043

Stent
MICROVENTION INC.
214049-LVIS-C
In Commercial Distribution

  • 00810170019043 ()

  • 5.5 mm x 34 mm
214049-LVIS

  • Bare-metal intracranial vascular stent
< 1 ... 17 18 19 20 21 ... 53 >